Answers are grounded in this paper and cite their sources.
To the Editor: Inflammatory bowel diseases (IBDs) are pathological conditions characterized by chronic inflammation that is primarily the consequence of dysregulation of the immune response, occurring in patients with appropriate genetic predispositions.1, 2 Previous investigations have clearly suggested the association between thyroid diseases and ulcerative colitis (UC): epidemiological studies have demonstrated an increased prevalence of hyperthyroidism (1.34%),3 while the incidence of thyrotoxicosis was between 0.82%4 and 3.7%.5, 6 A Canadian population study based on the Manitoba IBD database including 8072 cases of IBD from 1984 to 2003 found a greater percentage of both Crohn's disease (CD) and UC patients having a number of autoimmune or immune-mediated disorders (including arthritis, asthma, bronchitis, psoriasis, and pericarditis) than controls.7 However, in this study an increased risk for thyroid disease overall was not found. The prevalence of thyroiditis was 0.23% in UC patients and 0.19% in CD (versus 0.15%–0.20% in controls). The aim of our study was to retrospectively assess in our cohort of Italian IBD patients, the co-occurrence of IBD diagnosis and diagnosis of thyroid disorders other than cancer. A population of 909 IBD patients (male 503, 55.33%; female 406, 44.67%) referred to our Gastrointestinal Unit from 1985 to 2008 was considered for the statistical analysis. A total of 60/909 IBD (6.6%) patients with co-occurrence of IBD diagnosis and diagnosis of thyroid disorders was found. Among these patients, 42/60 (70%) had a diagnosis of goiter (with a prevalence of goiter in our IBD population of 42/909 patients, 4.62%), whereas 18/60 (30%) had a diagnosis of Hashimoto thyroiditis (with a prevalence of thyroiditis in our IBD population of 18/909 patients, 1.98%) (Table 1). If we consider CD and UC patients separately, we found among the UC population 28 cases of thyroid disorders (28/445 UC patients, 6.29%; male 5/28, 17.86%; female 23/28, 82.14%), with 20 cases of goiter (20/445, 4.49%; male 3, 15%; female 17, 85%), and 8 cases of Hashimoto thyroiditis (8/445, 1.8%; male 2, 25%; female 6; 75%). Among CD patients we found 32 cases of thyroid disorders (32/464, 6.89%; male 14/32, 43.75%; female 18/32, 56.25%), with 22 cases of goiter (22/464, 4.74%; male 7/22, 31.82%; female 15/22, 68.18%), and 10 cases of Hashimoto thyroiditis (10/464, 2.15%; male 7/10, 70%; female 3/10, 30%). Three UC female patients with the co-occurrence of IBD and thyroid disorders also had a diagnosis of another immune-mediated disease (Table 2). If we compare data from our study with epidemiological data from European countries8, 9 the prevalence of goiter was quite similar (4.62 in our population versus ≈5% in Europe), while the prevalence of Hashimoto disease in our IBD patients was twice that in the European population (1.98% versus 0.6%–0.8%). The main limit of our study lies in the retrospective nature of the study itself. Large population-based studies are needed to try to clarify the underlying etiology of the coexistence of autoimmune thyroid diseases and IBD. Prevalence of Thyroid Disorders Among Our Population of IBD Patients Prevalence of Thyroid Disorders Among Our Population of IBD Patients Three Female UC Patients with Co-occurrence of IBD and Thyroid Disorders Also Had a Diagnosis of Another Immune-Mediated Disease Three Female UC Patients with Co-occurrence of IBD and Thyroid Disorders Also Had a Diagnosis of Another Immune-Mediated Disease
No takes yet. Share an insight, caveat, or question.
Cesarini et al. (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: